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ABSTRACT
While many have explored how vascular processes alter gap junction communication and
composition few have analyzed the role of specific gap junction connexin proteins in regulating
cellular communication and wound healing. Using RNA interference or peptide inhibitors to
downregulate specific connexins we examined the role of gap junctions in intercellular diffusion,
calcium excitation, and in mediating the expression of vascular regulators transforming growth
factor-P (TGF- P), prostacyclin, and endothelial nitric oxide synthase (eNOS).
siRNA inhibition of connexin 43 in porcine aortic endothelial cells (PAEC) significantly
decreased the diffusion distance of Lucifer yellow dye and cytoplasmic calcium levels after
mechanical wounding. Wound healing experiments suggested that stimulatory signals travel
through gap junctions containing connexin 43, while inhibitory signal travel through gap
junctions containing connexin 37. Connexin 43 and connexin 37 inhibition, alone or in
combination, reduced the levels of secreted latent TGF-0 in confluent PAEC monolayers after 24
hours of incubation. Human umbilical vein endothelial cells (HUVEC) behaved in a similar
manner. Inhibition of any one of the three connexins resulted in a marked increase in eNOS
concentration. Yet, TGF-0 was sensitive to simultaneous inhibition of connexins 37, 40, and 43
and prostacyclin was controlled by connexin 37 and/or connexin 40 but not connexin 43.
We have demonstrated how selective inhibition of gap junction connexin expression can
reveal the potent gap junction mediation of cellular communication, wound healing, and vascular
function. We demonstrate for the first time that connexin proteins play distinct roles in
vasoregulation with differential effects on TGF- P, eNOS and prostacyclin. This technique in
general and findings in specific may help explain density-dependent control of vascular signaling
and repair.
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1. INTRODUCTION
Cell-cell communication via gap junctions is essential to homeostasis of the vascular
endothelium. This thesis describes how specific modulation of gap junction connexins can shed
light on the differential role of specific gap junction proteins in intercellular communication and
the maintenance of vascular function.
1.1 Background
Endothelial and vascular smooth muscle cells are vital regulators of vascular function,
and research has focused on elucidating the signal transduction pathways relevant to blood flow,
ischemia, and neovascularization. Endothelial cells line the luminal aspect of the entire
cardiovascular system, and regulate vascular tone, thrombosis, atherosclerosis, angiogenesis, and
inflammation. The morphology of the continuous endothelial monolayers requires rapid
response and coordinated control of local cell migration and proliferation, response to arterial
injury [1, 2] and synchronized vasoconstriction and dilation. Paracrine activation of cells via
diffusion of growth factors has been argued to be the primary method of communication and
signal activation among aortic endothelium and associated smooth muscle cells. Endothelial
cells sense their external environment, through mechanical transduction, shear fluid flow, and
foreign recognition. Gap junctions play a role as well and are known to aid in intercellular ion
transport and the passage of small molecules such as adenosine triphosphate (ATP), cyclic
adenosine monophosphate (cAMP), and inositol triphosphate (IP3).
1.2 Connexins and their role in intercellular communication
The 20 known connexin genes in mammals are named based on their molecular weight in
kilodaltons (KDa) [3]. Connexins have four transmembrane domains with two extracellular and
one intracellular loop, and allow the transfer of small molecules up to 1 KDa in size. Within
each cell, gap junctions join together in a hexameric arrangement, forming a gap junction hemi-
channel. This hemi-channel, or connexon, is then apposed to another hemi-channel on an
adjacent cell, forming a pair of hexamerically-arranged proteins that form complete gap junction.
There are three classes of gap junctions, depending on the distribution of gap junction proteins.
When all twelve proteins in the hexameric pair are identical, a homotypic gap junction is formed.
Alternatively, a heterotypic gap junction plaque is formed when the two hemichannels are
composed of a different connexin types, and a heteromeric gap junction is formed when each
hemichannel contains more than one type of connexin protein. It is not known how the
distribution of these various gap junction types is determined, nor whether there are differences
in how they form.
One of the more intriguing aspects of the connexin family of proteins is the varied
distribution of connexin proteins depending on species type and location in the vascular tree [4,
5]. Connexin 43 is considered to be ubiquitous throughout the human aorta and the arterioles,
yet its appearance and that of other connexin proteins in different vascular tree networks and
between species is subject to much current debate. For example, currently there is considerable
controversy regarding the composition of gap junctions in mouse endothelium, in particular as to
whether connexin 43 is present at all [6]. An endothelial-specific connexin 43 knockout mouse
exhibited hypertension and bradycardia [7], while other groups have verified the existence of
connexin 43 in only certain segments of the vasculature [8-12]. To confound the issue, there
have been reports of wide cross-reactivity in antibodies to specific connexins [9, 10, 13, 14]. In
light of these as yet unresolved issues we avoided use of connexin antibodies and murine
endothelial cells. All of the work we present utilized pig and human-derived endothelial cells.
Although the critical mass of research on the porcine endothelium pales in comparison to
that of the mouse, results are consistent. Only connexins 43 and 37 have been identified
immunohistochemically in porcine cells [15]. Fluorescent dyes, patch clamp conduction
measurements, and caged IP 3 (inositol triphosphate) demonstrated intercellular coupling,
although the differential contributions of connexin 43 versus connexin 37 were not explored. It
is thought that growth factors may affect intercellular coupling using these aforementioned
techniques. Thus, the selective permeability characteristics of these two connexin proteins with
respect to the type of gap junction (i.e. homotypic versus heterotypic) is an interesting question
to answer. In addition, it might be worthwhile to explore whether the transport through gap
junctions of particular molecules is promoted or inhibited via regulation of gap junctions. Such
permeability characteristics may or may not be regulated via compensatory mechanisms of gap
junctions, yet this issue has not been explored sufficiently in depth. To date, there has not been a
rigorous analysis of the relationship between the family of relevant growth factors and connexin
proteins, and much work remains to be done.
The response of endothelial cells to post-angioplasty is an important process that is still
not completely understood. Ideally, one should be able to increase wound healing to prevent
smooth muscle growth, intimal hyperplasia and associated clinical restenosis. In-vitro, connexin
43 expression increases with time in culture, while in wounded cultures, connexin 43 expression
reaches a maximum level at 4 hours and returns to control culture levels after 24 hours [16]. As
connexins have been implicated in regulating growth, it may be valuable to explore further
whether the various connexins play distinct roles in promoting cell spreading and migration soon
after wounding, and perhaps proliferation later on if the wound is sufficiently large. This can
only be done with a high-resolution model of the temporal and spatial effects of synergy between
gap junctions and growth factors.
Within seconds after endothelial cells are wounded, such as after balloon angioplasty,
Ca 2+ levels are increased in adjacent cells, normally on the range of 10 to 12 rows from the
wound edge at a velocity of around 20 to 28 jLm/sec [17]. There has been much interest in
clearly establishing the permeability characteristics of gap junctions, yet there is only an
incomplete picture of gap junction selectivity. Previously, it was believed that that gap junctions
have little if any ion charge selectivity. For example, connexin 43 homotypic gap junctions have
been reported to allow equal permeation of cations and anions [18, 19]. Connexin 40 channels,
on the other hand, are thought to prefer the permeation of K+ five times as much as that of Cf1
[20]. More recent studies have shown that a combination of factors, such as molecular size,
shape, and charge, coupled with the composition and conformation of the gap junction, help
determine the permeability of a molecule through the gap junction [21]. Once formed, gap
junction communication can be regulated in a variety of ways, such as the number of channels
and the single channel conductance (Figure 1). Another study has examined the flow rates of the
fluorescent dye Lucifer yellow through connexin 43 or connexin 40 homotypic gap junctions.
Their results suggest that approximately 1560 molecules can pass through a connexin 43
homotypic gap junction in one second, while the rate for a connexin 40 homotypic gap junction
is much less, at approximately 300 molecules/second [22]. Such a finding may have significant
clinical relevance in the case of atrial fibrillation, where the ratio of connexin 40 to connexin 43
homotypic gap junctions appears to be altered from normal conditions [23].
Figure 1. Gap junction-mediated intercellular coupling may be regulated by a variety of
approaches. The coupling of gap junctions, comprised of the connexin family of proteins, is
controlled by both positive (pointed arrows) and negative (flat arrows) regulators that serve to
alter the intercellular transport of small molecules. [3]
1.3 The role of connexins in regulating vascular function
Connexins are regulated by several vascular function mediators such as growth factors
and vasodilators. However, the literature has rarely explored the reverse - the question of
whether connexins themselves, regulated at either the mRNA (synthesis) or functional level
(Figure 1), might alter key components of vascular function. During arterial injury by balloon
angioplasty, there are several vasoactive molecules and processes that contribute to intimal
hyperplasia and acute arterial occlusion, with unclear dependence on intercellular coupling [24].
1.31 Prostacyclin is a vasodilator secreted by endothelial cells
Endothelial cells produce the eicosanoid prostacyclin, which prevents platelet formation
and is a vasodilator. It is believed that endothelial cells are the primary producers of prostacyclin
and that they produce far more than adjacent vascular smooth muscle cells. The activity of
prostacyclin is generally determined by cell surface receptors on these smooth muscle cells.
Prostacyclin also indirectly increases nitric oxide levels by inhibiting platelet formation, which
can prevent nitric oxide release. The role, if any, of gap junction communication in regulating
the production of prostacyclin by prostacyclin synthase has not been explored. The relationship
between connexin proteins is thus not only important in the situation of wound healing, but may
also be important for the maintenance of vascular tone and thrombus formation.
1.32 Plasma nitric oxide levels are regulated by endothelial nitric oxide synthase (eNOS)
It has been suggested that lack of connexin 43 in the endothelium might lead to an
increase in plasma nitric oxide, a vasodilator [7]. The enzyme endothelial nitric oxide synthase
(eNOS) produces nitric oxide and citrulline by using L-arginine as a substrate (Figure 2). eNOS
results in the phosphorylation of potassium channels, and by acting as a vasodilator leads to
hyperpolarization and the prevention of vasoconstriction. Huang et al [25] have also shown that
knockout of eNOS leads to an increase in arterial blood pressure. A decrease in the production of
nitric oxide has been implicated in early atherogenesis, coronary artery disease, and general
endothelial dysfunction [24]. Nitric oxide is produced in the endothelium from L-arginine by
endothelial nitric oxide synthase and acts in conjunction with gap junctional signaling (Figure 2).
Nitric oxide is essential in preventing detrimental effects on the vascular wall and inducing repair
after balloon angioplasty and arterial injury. For example, NO decreases smooth muscle cell
migration and proliferation, increases endothelial cell migration and proliferation, and prevents
platelet adhesion to the wall of the vessel [24]. As the reduction of connexin 43 in mice
increases nitric oxide levels [7], a therapeutic agent or combination of therapeutic agents that
could regulate connexin expression, and subsequently alter nitric oxide levels, might prove to be
valuable.
1.33 Transforming growth factor-beta is both a positive and negative regulator of endothelial
cells and vascular smooth muscle cells
Transforming growth factor-beta (TGF-P), released by endothelial cells with vascular
injury is another essential element of vascular homeostasis. TGF-3 is both a positive and
negative regulator of migration, proliferation, remodeling, and extracellular matrix (ECM)
production in endothelial cells and vascular smooth muscle cells (vSMC). In vSMC, TGF-1
promotes the production of a-smooth muscle actin (a-SMA), and at low concentrations it
promotes vSMC proliferation by activating platelet derived growth factor (PDGF). In general,
the mode of action of TGF-3 is vascular state and dosage-dependent, and it is unknown whether
signals traveling through gap junctions mediate either its secretion from cells or its activity. The
limited knowledge we have suggests that TGF-3 increases connexin 43 [26], though the reverse,
the effect of regulating gap junction functionality on active and latent TGF-3, has not been
explored. As can be seen from a recent model of gap junction communication (Figure 2), there
does not appear to be any direct relationship between gap junction communication and the
growth factor.
Figure 2. Cell to cell communication in the arteriolar wall (from Figueroa et al. 2004 [27]).
Gap junctions regulate membrane potential and calcium transfer, as demonstrated by the red and
blue lines, respectively. Others in our group have focused on the relationship between IP 3 and
Phospholipase C-y (PLC-y) and associated gap junction communication. Notice that the figure
demonstrates both homocellular communication between like cells and heterocellular
communication between endothelial and smooth muscle cells. Abbreviations: ER (endoplasmic
reticulum); NOS (nitric oxide synthase); T+L (T and L type calcium channels); al and a2
(adrenoreceptors); M (Ach muscarinic receptor); B2 (bradykinin receptor).
1.4 Targeted regulation ofgap junction communication
To date, connexin proteins have been regulated in a wide variety of biological systems
including the cardiovascular system, neuronal conduction, and angiogenesis in the eye. While
many of the functional assays that can measure intercellular communication and selectivity, the
field has lacked in its ability to explore the role of individual connexins, and formed gap
junctions, in a specific manner. Researchers have unfortunately had to rely on a variety of
molecules exhibiting off-target effects that do not specifically target the family of connexin
proteins. Thanks to the increased availability and efficacy of specific protein regulation using
RNA interference, and Cre-Lox recombinant technology, it has become possible to further
elucidate the vascular function of gap junctions by regulating the connexin family of proteins.
To our knowledge, there are no published data regarding the vascular response of endothelial
cells with overexpressed gap junctions. However, human umbilical vein endothelial cells
(HUVEC) treated with homocysteine to mimic hyperhomocysteinemia exhibited increased
connexin expression through the overexpression of connexin 43 tagged with green fluorescent
protein (GFP) [28]. Because of the predicted importance of gap junctions in maintaining
vascular function such as vascular tone, remodeling, and cellular communication, there are a
plethora of both applied and approved patents on pharmacological gap junction regulation. Yet,
because of off-target effects and toxicity of these gap junction blockers, it is unclear whether the
use of any of them would ever be approved for use in the clinic.
1.41 Non-specific regulation ofgapjunction proteins
The pharmacology of gap junctions involves a broad variety of drugs whose mechanisms
of action are predominantly unknown. In cells with large conductance, researchers may take
advantage of changes in Na+, Ca2+, Mg2+, and pH to alter gap junction conductance and
consequently, intercellular communication [29]. However, because endothelial cells are
preprogrammed to communicate over short distances and instead rely on diffusive and bulk flow
in the lumen, the usefulness of changing ion concentration in these systems is limited. One of
the prototypic non-specific molecules used to target endothelial cells is the polycyclic glycoside
ouabain [30]. For it to be effective in preventing the trafficking of connexin 43 and connexin 40,
it must be used at the high concentration of 1 mM, leading to cell toxicity and exceeding the
therapeutic concentration window. Similarly, stimulation of the c-AMP pathway via treatment
with amines such as histamine, adrenaline, and noradrenaline is seen as a method to increase
coupling between gap junctions, although their method of action remains unclear [31]. Among
the most common connexin inhibitors is 18-a-glycyrrhetinic acid (18-a-GA), which alters the
phosphorylation state of connexins by acting indirectly on protein kinases, and palmitoleic acid,
which uncouples already formed gap junctions [32]. Other non-specific inhibitors have been
suggested to dissolve in membrane lipids, and lead to changes in membrane composition,
effectively squeezing closed gap junctions, though they exert other non-specific effects such as
closing shut ion channels as well [33]. For a more detailed list of chemical regulators of gap
junctions, the reader is referred to excellent reviews by Salameh et al [3] and Evans and Boitano
[33].
Antisense technology, despite its potential of eliciting an immune response, has been
successful in creating therapies that enhance the rate of wound closure of excisional and
incisional skin wounds in mouse models. In a particular study [34], connexin 43 antisense
oligonucleotides delivery in a Pluronic gel were applied to skin wounds and enhanced wound
closure. However, these effects, shown in the epithelium, have not been repeated in the
endothelium to demonstrate a change in wound closure rate in clinically relevant situations like
post-angioplasty restenosis.
Another area of research has been the use of non-conventional cell lines to explore the
role of connexins in wound repair and intercellular coupling through gap junctions. In particular,
Kwak et al [35] used a Pym-T transformed mouse brain endothelial cell line (bEnd.3) and human
cervical carcinoma HeLa cells to decrease connexin 43 expression through dominant negative
expression of connexin 43-GFP and connexin 43-connexin 32 fused proteins. bEnd.3 cells,
despite expression of von Willebrand factor and uptake of acetylated low density lipoprotein, are
a transformed cell line, and as such exhibit loss of cell cycle control, are largely not effected by
passage number because of telomere dysfunction, and most importantly are growth factor
insensitive. As the role of growth factors such as TGF-P, VEGF, and FGF2 have been shown to
be critically important for the function of endothelial and smooth muscle cells, it is essential to
use model systems that not only are growth factor dependent but also exhibit differential
response based on the age of the cells. Our lab has shown the age-dependent in-vivo and in-vitro
proliferative response of smooth muscle cells in response to FGF-2 and heparin [36].
1.42 Specific regulation ofgap junction communication
Ideally, it should be possible to regulate connexin expression and the functionality of gap
junctions on demand without the non-specific effects associated with many of today's gap
junction regulators. Furthermore, while a vascular endothelial cell-specific knockout of
connexin 43 has been made in mice using the loxP/Cre system [7], there have been no follow-up
studies in five years since the publication, perhaps because limited access to the knockout mice,
inability to regulate connexin 43 on demand, or because of the pervasive controversy of whether
endothelial connexin 43 even exists in mice. Since 1978, sequence-specific oligonucleotides
have been used to alter gene expression, originally in the Rous sarcoma virus [37]. We early on
used antisense nucleotides to prevent cardiovascular disorders [38], and today antisense
oligonucleotides are still used, usually via translational blocking or activation of ribonuclease H
(RNase H) [39].
In 1998, the joint groups of Fire and Mello discovered that using double stranded RNA
led to sequence specific silencing in C. elegans [40]. Several years later, Elbashir et al [41]
showed that keeping the double stranded RNA sequences to approximately 21-23 nucleotides
prevented non-specific immune effects in mammalian cells, dubbing the new sequences short
interfering RNA (siRNA) that consequently cause RNA interference (RNAi). RNAi are less
toxic than antisense oligonulceotides at equal concentrations and lead to greater mRNA
knockdown. Since the publication by Elbashir et al, the use of this technology to elucidate gene
function has skyrocketed, and many companies such as Alnylam Pharmaceuticals (Cambridge,
MA) have been founded with this technology at their foundation. Using siRNA to silence
connexin expression would allow experimenters to avoid non-specific effects of previous
connexin inhibitors and enable regulation of connexin expression in-vitro on demand.
Furthermore, a dosage response of siRNA can be used to establish a relationship between
connexin mRNA. levels in relation to gap junction function (Figure 3).
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Figure 3. Pathway of short interfering RNAs silencing gene expression (from Dykxhoorn et
al, 2003 [42]). a) Typical siRNA's have 2 unpaired nucleotides at opposite ends, while the 5'
ends are phosphorylated and the 3' ends are unphosphorylated. b) The double stranded RNA is
cleaved by Dicer into short interfering RNAs (siRNA's), which are incorporated into the RNA-
inducing silencing complex (RISC). The unwinding of the siRNA is ATP dependent, and once
unwound the strands find their complementary site, and the target mRNA is then cleaved.
When examining functional roles of proteins using RNA interference, it is important to
determine temporal effects as well as the level of down-regulation. Connexins have been
experimentally determined to have a half-life of approximately 108 minutes in bovine aortic
endothelial cells [43], and mRNA transcription does not become sizably reduced until a few
hours later. The degradation pathway of connexins is thought to be primarily proteasomal, but
also is known to degrade lysosomally as well [44]. Because of the transient nature of RISC
activation and RNA silencing, one could thus examine the effect of varying levels of gap
junction functionality on selective permeability, dye and calcium transfer, and vascular response
_·
such as a difference in the wound healing rate. RNA inteference has had some success in
improving our understanding of connexin biology, and one of the many components of this
thesis was to leverage this technology to improve the understanding of inter-endothelial cell
coupling as they relate to gap junctions. Recently, Shao et al [45] showed that downregulating
connexin 43 in breast cancer cell lines and normal rat kidney cells exhibited a breast cancer cell
phenotype. Specifically, thrombospondin-1 expression was reduced and VEGF expression was
increased. Another study published around the same time showed that connexin 43 association
with N-cadherin in a multiprotein complex was necessary for gap junction formation in NH3T3
mouse embryonic fibroblasts [46]. Perhaps the most relevant finding was the use of short
interfering RNAs and connexin mimetic peptides to elucidate heterocecllular contact between
endothelial cells and smooth muscle cells. This study, done in murine in-vitro cultures,
suggested that connexin 43 and 37 is found in both aortic endothelial cells and smooth muscle
cells but connexin 40 is exclusive to the former [47]. Furthermore, connexin 37 was not found at
the interface between the endothelial cells and smooth muscle cells, and in this model system this
particular connexin is not thought to be involved in heterocellular communication.
Recombinant and transgenic DNA technology has also been useful in evaluating the role
of connexins with respect to cardiac malformation, hypotension, and bradycardia in mice. In
1995, Reaume et al showed that mice whose connexin 43 had been mutated exhibited cardiac
malformations, and most died shortly after delivery by caesarian section [48]. Because the
mutation was in all cell types, the mice exhibited other symptoms including neck swelling,
swollen abdomens and stomachs, although the majority of problems were still in the heart.
Interestingly, although a larger percentage of cells in heterozygotes did not exhibit dye transfer,
in those that did the average distance of communication was higher than in wild type mice.
This study was followed in 2001 by another group that created a Cre-Lox recombinant
mouse whose endothelial cells had connexin 43 knocked out [7]. This paper showed that that
connexin 43 knockout mice exhibited hypotension. One of the aims of this thesis was to
elucidate the reasons behind the increase plasma nitric oxide levels seen in these mice, seen
through measurement of the sum of nitrate (N0 3-) and nitrite (NO2-) levels. The changes in the
levels of nitric oxide might be due either to an increase in specific activity or in production of
endothelial Nitric Oxide Synthase (eNOS) [49-51].
Connexin mimetic peptides, which exhibit the extracellular loop regions of connexin and
prevent them from docking (Figure 4), have gained popularity within the last several years [52-
55]. The peptides have no known homology to any other protein in the human, mouse, rat, or pig
genomes, and although they are used in relatively high concentrations, they are highly purified
and not harmful to the cells. They were originally developed by screening different peptides that
bind to the extracellular loops of connexins in cardiac myocytes of chick hearts [56]. Besides the
obvious advantage of specificity in using these peptides, addition of the peptides is reversible
and the variety of sequences, with varying "silencing ability" and different connexin targets,
allows for elegant experimentation. The variety of connexin mimetic peptides allows one to
target various connexins: 43Gap26 targets only connexin 43, 3740Gap26 targets connexin 37
and 40, and 3743Gap27 targets connexins 37 and 43.
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Figure 4. Connexin mimetic peptides inhibit connexins by binding to their extracellular
loops and preventing the docking into functional gap junctions (Image from Evans and
Boitano, 2001 [33]).
1.5 Specific Aims
This thesis sought to improve the understanding of the role that various connexin
proteins, which comprise gap junctions, have in endothelial communication and maintenance of
vascular function.. Specifically, the thesis explored the role of gap junctions in key events in the
vascular response to arterial injury, including short distance communication, wound healing,
calcium elevation, and effectors of vascular homeostasis such as transforming growth factor-13,
prostacyclin, and nitric oxide. Prior to experiments, it was hypothesized that each of the
connexin family of proteins plays a distinct role in the functionality of gap junctions, and that the
critical role of these gap junctions can be equally seen by regulating them at either the
transcriptional or functional level.
2. MATERIALS AND METHODS
2.1 Endothelial cell isolation
Pig aortae were obtained from a local abattoir (Research 87, Boylston, MA) within 1-4
hours of harvest. Tissues were immersed in Phosphate-Buffered Saline (PBS) (Invitrogen,
Carlsbad, California) with 2% penicillin-streptomycin (PS) at pH 7.4 in a sterile container.
Endothelial cells were isolated using a modified version of a protocol developed by Dr. David
Ettenson [57].
Upon arrival, the aortae were washed by transferring them using long blunt forceps to a
fleaker containing PBS (2% PS). Careful attention was taken to avoid damage to the vascular
intima by grasping the aorta by the perivascular fat. Aortae were removed from the bottle and
placed in a 150mm-culture dish with minimal PBS (2% PS). The fat and connective tissue was
then removed with sterile surgical scissors, making sure not to cut the vessel. The adventitia was
also trimmed thoroughly with fine scissors and forceps. All tissue samples were disposed via
incineration. The trimmed aortas were then placed in a new beaker containing PBS (2%PS),
clamped with sterile hemostats just above the take-off of the first large branch and the distal
vessel was cut away and discarded. The hemostats holding the clamped aortae were used to
position the vessels upright. PBS (2% PS) was pipetted twice into the clamped vessels to wash
away any remaining blood cells from the lumen of the aortae.
Warm Collagenase Class II solution (Worthington Chemical, Lakewood, NJ) was
prepared at 0.75 mg/ml in PBS (2% PS), sterile filtered, and added to the aorta at 370 C for 8
minutes. After the collagenase solution was removed, endothelial cells were removed from the
intimal surface by means of gentle rinse with warmed growth media along the vessel from
bottom to top. The effluent medium from each aorta was collected into a test tube, and 1 ml was
added to a 35mm tissue culture dish, to which an additional 1 ml of fresh medium was added.
Isolated cells grew undisturbed for two days, after which fresh media was added, while allowing
25% of the conditioned media (0.5 ml) to remain in the dish. The culture was changed every two
days until the dish was confluent, usually after one week's time. During this initial growth
period, cells were checked every few days and discarded if contaminated with bacteria or smooth
muscle cells.
2.2 Maintenance of cell cultures
Porcine aortic endothelial cells (PAEC) were maintained in low glucose Dulbecco's
Modified Eagle's Medium (DMEM) (Invitrogen) containing 5% fetal bovine serum (Hyclone,
Logan, UT), 1% glutamine, and 1% penicillin-streptomycin antibiotics. Cells were grown in an
incubator at 370 C and 10% CO2 and media was decanted and replaced every two days. Cells
were passaged by incubating in trypsin, 2% ethylenediaminetetraacetic acid (EDTA) from
Invitrogen for 5 minutes. Cells were split in a 1:5 ratio, and for cell-density dependent
experiments, cells were counted using a Coulter Particle Count & Size Analyzer Z2 (Beckman-
Coulter Fullerton, CA). To count cells, cell suspensions were diluted 1:10 in Isoton II Solution
(Beckman-Coulter) in a blood cell counter vial with snap cap (USA Scientific Ocala, FL).
Cell populations were cryopreserved in 10% DMSO in DMEM medium (20% FBS,
I%PSG). Confluent monolayers were trypsinized and resuspended in 5 ml of the
DMSO/DMEM solution. 1 ml aliquots were made in cryovials, and the vials were placed in a -
20 0 C freezer for 2 hours, and then transferred to a -800C freezer overnight. The cryovials were
then placed in the -135 0 C until future retrieval.
Porcine aortic endothelial cells (strains AG12071 and AG12364) were also obtained from
the Coriell Cell Repositories at the Coriell Institute for Medical Research (Camden, NJ). Cells
were shipped overnight in oxygenated, media filled T-flasks. Cells that were initially grown on a
gelatin matrix were successfully adapted for growth on tissue culture polystyrene. All
experiments were performed on cells passage 6 or below. Human umbilical vein endothelial
cells (HUVEC) were obtained from Cambrex (East Rutherford, New Jersey) and maintained in
Endothelial Cell Medium-2 supplemented with SingleQuot® Kit and FBS. Final serum
concentration was 7% and cells were maintained at 370 C and 5% CO 2.
2.3 Acetylated-Low Density Lipoprotein (LDL) Uptake Assay
Endothelial cell identity was verified by uptake of acetylated low-density lipoprotein.
Cells were grown to 90% confluence, and were incubated at 370 C for four hours in 10 ýtg/ml
DiI-Ac-LDL (Biomedical Technologies Stoughton, MA) in complete growth medium. Stock
DiI-Ac-LDL concentrations of 200 ptg/ml were diluted in respective growth media. Cells were
washed with PBS, fixed with 4% paraformaldehyde for 20 minutes, washed twice with PBS for
10 minutes, and were subsequently incubated with Hoechst nuclear stain (1:100) for 10 minutes.
Cells were visualized after two more washes with PBS and incubation in minimal PBS to prevent
drying.
2.4 Cell Wounding
Cells were mechanically wounded to mimic arterial injury. A Coming Cell Scraper
created a single straight wound on monolayers that had been confluent between 48 and 72 hours.
It was not possible to take advantage of time-lapse microscopy because of the number of
conditions and long-duration tracking time of the wounds. Instead, a triangulation scheme using
ordinary tissue culture plates was developed that made it possible to measure wound repair at
any time. Prior to wounding, tissue culture plates were marked diametrically on the outsides of
the walls, so that the two marks meet at the center of the plate (Figure 4). Next, a mark was
made on the bottom-side of the plate near the center, to the side of the "diameter" formed by the
two marks on the walls. Subsequently, a straight wound was made along the line on the walls.
To locate the image, the mark was located and placed so that it would be immediately vertically
above the field of view, and horizontal adjustment was done using the wall marks. Images were
taken on a Nikon (Melville, NY) Diaphot Phase Contrast Microscope with attached Nikon D70
digital camera.
Figure 5. Experimental setup for wound healing experiments (Note: not to scale). Marks
were made on two sides of the dish as well as the bottomside of the dish to ensure the same
wound area was being observed throughout the experiment time course. Figure made using
Blender 3D modeling software.
2.5 Lucifer Yellow Dye Transfer Assay
Heterotypic dye transfer was assessed through scrape loading of Lucifer yellow lithium
CH salt (Invitrogen). Briefly, 0.5 mg/ml Lucifer yellow solution in PBS was added to confluent
endothelial cell monolayers. The monolayers were wounded mechanically with a cell scraper,
and were incubated for 15 minutes in the dark to minimize photobleaching. The cells were then
washed twice with PBS and then fixed with 4% paraformaldehyde for 20 minutes. Dye transfer
was visualized on the FITC wavelength on a DMRA2 fluorescent microscope (Leica
Microsystems Bannockburn, IL) equipped with a Hamamatsu (Bridgewater, NJ) C4742-95
digital camera digital camera attached to a Windows XP computer running Metamorph software.
2.6 Neurobiotin Dye Transfer Assay
Media was changed and replaced with 1 mg/ml neurobiotin, diluted in PBS. Cells were
mechanically wounded using a cell scraper, and incubated in the dark for 15 minutes. After
washing twice with PBS, cells were fixed with 4% paraformaldehyde for 20 minutes, and
washed again twice with PBS. Cells were incubated for 3.5 minutes in 0.1% Triton X-100, and
washed twice for 10 minutes in PBS. The cells were stained with streptavidin conjugate (1:200)
for one hour, and washed again twice with PBS for 10 minutes, making sure to leave enough
PBS to prevent the cells from drying out.
2.7 Calcium Fluo-4 Assay
Fluo-4 Am was used as a fluorescent indicator to measure intercellular calcium signaling.
Originally, assays using a provided quencher dye were used, and exhibited significant
background fluorescence, resulting in unacceptable images of calcium transfer. Instead, Fluo-4
No Wash (NW) Calcium Assay Kit from Molecular Probes (Eugene, OR) was used. Probenicid
solution was mixed with IX Hank's Buffered Salt Solution in 20 mM HEPES, according to
manufacturer's instructions. Probenicid solution was then added with HBSS solution to the
Fluo-4 NW dye mix to make the dye loading solution. Best results were seen when the plates
were incubated at 370 C for 30 minutes, and then at room temperature for an additional 30
minutes. As these were live cell assays, the cells were not fixed with paraformaldehyde.
Immediately after cell wounding, calcium transfer was examined and images were taken at the
point of maximum calcium transfer, usually after several seconds. Images were taken at settings
optimal for excitation at 494 nm and emission at 516 nm.
2.8 siRNA Knockdown of Connexin 43
Connexin 43 was silenced using short interfering RNA's. Cells passage five or earlier
were plated at a density of 120,000 cells/ml the day before transfection, so that they were 90-
95% confluent the following day. Optimized conditions were found after trying various
transfection protocols and reagents. Specifically, Ambion's NeoFX, siPORT Amine, and
Invitrogen's Lipofectamine 2000 all caused unacceptable cell toxicity and death and effected cell
morphology. Silencer Custom siRNA was ordered from Ambion (Austin, TX) targeting
connexin 43 protein with standard purity in annealed powder form (Table 1). siRNA was
resuspended in RNAse free water to a concentration of 20 uM. siLentFect Lipid Reagent
(BioRad) was used to transfect siRNA into porcine aortic endothelial cells. Half an hour prior to
transfection, media was aspirated and 1 ml of standard growth medium was added to each well
of a six well plate. Once the diluted siRNA and transfection agent were mixed in various
concentration ratios, they were incubated for 20 minutes to form transfection complexes, and the
cells were transfected for 5 hours at 370 C. After five hours, the cells were washed twice with
PBS and incubated in growth media with 17% FBS.
Table 1. Short interfering RNA sequences targeting
Sense Sequence (5'->3')
Sequence 1 CAGUCUGCCUUUCGCUGUAtt
Sequence 2 GCUGGUCACUGGUGACAGAt t
Connnexin 43 mRNA [46].
Antisense Sequence (5'-) 3')
UACAGCGAAAGGCAGACUGtt
UCUGUCACCAGUGACCAGCtt
2.9 Connexin-Mimetic Peptide Gap Junction Regulation
Connexin-mimetic peptides were used to regulate gap junctions. Briefly, HPLC-purified
peptide in lyophilized form obtained from Alpha Diagnostic (San Antonio, Texas) and the MIT
Biopolymers Laboratory (Cambridge, MA) was dissolved to an initial concentration of 3.8
mmol/L in Hank's Buffered Salt Solution (Invitrogen) with 25 mmol/L HEPES. Peptides were
dissolved to a final concentration of 190 gmol/L [47] in DMEM with 5% FBS and 1%
glutamine, penicillin and streptomycin for PAEC cells or diluted to the same concentration in
Endothelial Cell Medium-2 supplemented with SingleQuot® Kit and 7% FBS. The sequence of
the three peptides used can be seen in Table 2. Despite previous protocols mentioning the use of
3743GAP27, it was determined that because of its extreme hydrophobicity, it is not possible to
dissolve it in conventional HBSS/HEPES or growth media, and experiments were done only on
the remaining two peptide sequences.
Table 2. Amino acid sequences of connexin-mimetic
peptides used to regulate the function of gap junctions.
Peptide Name and Target Amino Acid Sequence
43GAP26 VCY DKS FPI SHV R
3740GAP26 VCY DQA FPI SHI R
3743GAP27 SRP TEK TIF II
2.10 Enzyme-Linked Immunosorbent Assay (ELISA)
Porcine and human transforming growth factor P (TGF- p1) were analyzed by species-
specific Quantikine ELISA kits from R&D Systems (Minneapolis, MN) according to
manufacturer's protocol. 6-Keto-Prostaglandin Fl,, an indicator of prostacyclin formation, was
analyzed using the Enzymeimmunoassay Biotrak (EIA) System from Amersham Biosciences
(Piscataway, NJ). Experiments on conditioned media were done on cells three days post-
confluency. Briefly, cells were washed twice with growth media, and incubated for 45 minutes
in growth media which was then aspirated and replaced. The conditioned media was collected
24 hours later, centrifuged at 300 x g for 5 minutes, and the supernatant immediately stored at -
800C until further use. Human endothelial nitric oxide synthase (eNOS) was analyzed using a
human eNOS Quantikine ELISA kit from R&D Systems (Minneapolis, MA). Because the
enzyme is exclusively membrane bound, conditioned media could not be used. Cells were
washed twice with PBS, and 700 il of cell lysis buffer (provided in kit) on ice was added to the
cells in 35 mm tissue culture plates. The cells were incubated for 20 minutes in the cell lysis
buffer, and were subsequently scraped with a cell scraper. The contents of the plate were
transferred to polypropylene tubes and centrifuged at 300 x g for 5 minutes. The supernatant
was removed and stored at -800 C until analysis. Total TGF-3 concentration was determined by
activating the latent form. To active all latent TGF-0 in the media, IN HCI and 1.2 N
NaOH/O.1M HEPES were sequentially added to conditioned media according to manufacturer's
protocol (R&D Systems). After absorbance values were converted to concentration using a
standard curve, activated TGF-0 was subtracted from non-acid treated TGF-0 sample to provide
the amount of latent form of the protein.
2.11 Isolation of Total RNA
Total RNA was isolated using the QIAGEN (Valencia, CA) RNeasy Mini Kit via a
slightly modified version of manufacturer's protocol. Cells were trypsinized for 5 minutes at
370 C and then were spun down at 5000 rpm for 5 minutes. Cells were homogenized using
QIAGEN QIAshredder columns, and DNase was used to digest any DNA on the columns using
the Qiagen RNase-Free DNase Set. RNA samples were immediately stored at -800 C prior to
use.
2.12 Real Time RT-PCR
Reverse Transcription was carried out using Taqman Reverse Transcription Reagents
(Applied Biosystems, Foster City, CA). RNAse-free water from Invitrogen was used as
appropriate to reconstitute primers, and for the reverse transcription and real time PCR
procedures. Components and respective concentrations of the reverse transcription step may be
seen in Table 3. All reverse transcription experiments were carried out in 0.2 ml strip tube caps
(Molecular Bioproducts, San Diego, CA). The enzymatic components were added first and
vortexed briefly. Next, the non-enzymatic components were added and the total contents were
mixed by inversion. Once the reverse transcription components were added, 10 jl White, Light
Mineral Oil from Mallinckrodt N.F. (Hazelwood, MO) was carefully added to the side of the
strip tubes and was allowed to create a clean phase separation as the top layer of the reaction
mixture. Attention was taken to prevent mixture of the two phases. The reverse transcription
were performed on a RapidCycler (Idaho Technology, Salt Lake City, UT) using the schedule
shown in Table 4.
Table 3. Enzymatic and Non-enzymatic components for reverse transcriptase reaction.
Component Volume/tube (Il) Final Concentration
Enzymatic Components
RNase-free water 10.4
10X TaqMan RT Buffer 4 1X
25 mM MgCl2  8.8 5.5 mM
deoxyNTP Mixture (2.5 mM 8 500 jgM per dNTP
each)
Oligo d(T)16 2 2.5 gM
Non-enzymatic Components
RNase Inhibitor (20 U/L) 0.8 0.4 U/L
MultiScribe Reverse 1 1.25 U/pl
Transcriptase (50 U/ptL)
RNA Template 5 Unknown concentration
Table 4. Reverse transcriptase temperature schedule for thermocycler.
Time (minutes) Temperature (*C)
Incubation 10 25
Reverse Transcription 30 48
Reverse Transcriptase Inactivation 5 95
Desalted primers were obtained in lyophilized form from Invitrogen, and were reconstituted in
RNase-free water to a concentration of 30 pM. Real Time PCR was conducted using the SYBR
Green Mastermix kit from Applied Biosystems (Table 5) in Low 96-well White Multiplate PCR
Plates (Bio-Rad Hercules, CA). Each run was performed with RNA from the control sample,
where an equal volume of RNA was loaded instead of DNA. Furthermore, each run was also
performed with a primer dimer control, where no RNA or cDNA was added and an additional 3
gl of RNase free water was used to keep the reaction volume at 20 tl. Primer sequences
targeting porcine connexin 43 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which
was used to normalize RNA values, in shown in Table 6 below.
Table 5. Components used for Real Time Reverse-
Transcriptase Polymerase Chain Reaction (Real
Time RT-PCR)
SYBR Green Master Mix
cDNA (from Reverse Transcription Step)
RNase free water
Forward primer
Reverse primer
Total:
Volume
10 pl
3 gl
5 pl
1 pl
1 pl
20 pl
Table 6. Primer sequences used for Real-Time RT-PCR on
PAECs.
Primer Sequence
GAPDH Forward CCTTGGCAGCACCAGTAGA
GAPDH Reverse CCTCCTGTACCACCAACTGC
Connexin 43 Forward [58] TGTCTTCTTCAAGGGTGTTAAGG
Connexin 43 Reverse [58] CACTCGCTTGTTTGTTGTAATTG
Prior to the run, the plates were spun down on a Savant Speedvac Plus SC210A vacuum
centrifuge (Thermo Electron Corporation, Waltham, MA) at the MIT Biomicro Center. Samples
were run on the Biomicro Center's MJ Research DNA Engine Continuous Fluorescence Detector
using Opticon 2 software. Baselines were subtracted using the average over the cycle range.
The cycle number n was converted to transcript number t by using the equation t=2(-n+40)
2.13 Statistical Analysis
Student's T-Test on Microsoft Excel was used to analyze data. Statistical significance
was considered P < 0.05.
3. RESULTS
3.1 Positive identification of endothelial cell cultures
Cells were positively identified as endothelial in origin in 90% confluent cultures, and
negatively for presence of vascular smooth muscle cells or fibroblasts. Every nucleus stained
blue via the Hoechst nuclear stain, and exhibited red staining by acetylated-low density
lipoprotein in the surrounding cytoplasm (Figure 5). After reaching confluence cell cultures
underwent remodeling and both PAEC and HUVEC cells exhibited the prototypical cobblestone
morphology of confluent endothelial cells.
Figure 6. Acetylated low density lipoprotein (LDL) uptake assay and positive identification
of endothelial cell content. LDL uptake was assessed by incubation with DiI-Ac-LDL for four
hours (red). Nuclei stained via Hoescht nuclear stain (1:100, blue).
3.2 Altered gap junction permeability after siRNA mediated inhibition of connexin 43
Porcine aortic endothelial cells were successfully silenced using both siRNA sequences.
The results indicate that the knockdown profile is dependent on the amount of siRNA as well as
the amount of transfection agent used, and the expression of connexin 43 depends on a dose
response. After 5 hours in transfection media, and two washes with growth media, serum levels
in the growth media were doubled for twenty-four hours. At the end of this transfection period,
endothelial cells already began to show a dose and sequence dependent decrease in connexin-43
mRNA (Figure 6). The two sequences clearly differ in their efficiency of knockdown. At the
lowest tested concentration of 4 nM, siRNA Sequence 1 had already reduced connexin 43 levels
to 37% of control levels, while Sequence 2 was only slightly lower than the control sequence at
64% of control mRNA (Figure 6). When the concentrations of RNA were increased but the
amount of transfection agent was held constant, the connexin 43 mRNA level of Sequence 1 fell
to only 23% of control (P < 0.05), while that of Sequence 2 increased to 78% of control levels.
At 24 hours after transfection, the PAEC cultures were clearly responsive to altering
levels of both delivery vehicle and drug. All conditions exhibited statistically significant
knockdown of connexin 43 mRNA. To ensure that the transfection of the siRNA was not
causing non-specific effects on the endothelial cells, a negative control siRNA, which exhibits no
sequence homology to the porcine genome, was transfected at the highest concentration of RNA
and transfection agent used in any of the specific target sequences. As expected, the negative
controls had no discernable effect on connexin mRNA levels, remaining nearly identical to cells
that were not transfected (Figure 7). Successful silencing of connexin 43 was achieved after
several rounds of protocol optimization including unsuccessful transfection with several
transfection reagents, including Ambion's NeoFx and siPORT Amine, Invitrogen's
Lipofectamine 2000, and Genospectra's (now Panomics) ExpressSI Delivery Kit. These agents
demonstrated inadequate connexin 43 regulation and unsatisfactory cell viability.
Connexin 43 expression using siRNA Sequence 1 was significantly reduced compared to
both the control culture and negative control siRNA sequence. Results indicate that the
knockdown is responsive to both changes in RNA and transfection agent concentration. At a
concentration of 10 nM concentration for Sequence 1, connexin 43 mRNA was reduced by
97.4% compared to control sequences (Figure 7). Furthermore, using an alternative delivery
regiment of drug, connexin 43 was reduced to 54% of control sequences. At twice the
concentration of drug carrier, connexin 43 mRNA levels were reduced to merely 96.7% of
control levels.
Connexin 43 silenced with Sequence 2 did not show the same level of potency in
reducing gap junction levels after 24 hours, although they were still significantly reduced (Figure
8). At the most dilute concentration of transfection agent and RNA, connexin 43 levels were
reduced to 25.3% of control levels, while at 2.5 the concentration of RNA levels were reduced to
9% of control levels.
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Figure 7. Connexin 43 levels five hours post-transfection of siRNA. Connexin 43 levels as
examined via Real Time PCR analysis. 10 nM siRNA #1, 1:1667 Transfection Agent sample
significantly different (P < 0.05) from control.
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Figure 8. Dose-dependent response of Connexin 43 mRNA expression in response to
delivery of siRNA Sequence 1 to porcine aortic endothelial cells (PAEC), t=24 hours post
transfection. A negative control sequence, a random sequence with no known genome
homology, was used to verify that the delivery vehicle was not altering connexin expression by
itself. All conditions determined to be statistically different from control (P < 0.05)
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Figure 9. Dose-dependent response of Connexin 43 mRNA expression in response to
delivery of siRNA Sequence 2 to porcine aortic endothelial cells (PAEC), 24 hours post
transfection. A. negative control sequence, random and with no known genome homology, was
used to verify that the delivery vehicle was not altering connexin expression by itself. Both
conditions for Sequence 2 statistically different from control (P < 0.05)
3.3 Connexin 43 regulation alters calcium excitation in porcine aortic endothelial cells
Twenty-four hours after transfecting the cells, PAECs were examined for increases in
intercellular calcium levels via the calcium fluorescent tracer fluo-4. Upon mechanical
wounding an immediate transient increase in the levels of intercellular calcium were observed in
control cells, first beginning with the rows immediately encompassing the wound. Within
seconds, the calcium response moved away from the wound edge into the monolayer in a linear
manner. For both control and connexin-regulated cultures, calcium excitation was limited to
areas near the wound edge. Those cells that did exhibit an increase in calcium levels appeared to
have similar intensities, suggesting that the increases in calcium levels were not necessarily only
Control 10 nM Negative Control, 10 nM siRNA#2, 1:1667 4 nM siRNA#2, 1:1667 TA
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from intercellular transport of calcium through gap junctions, and could have been mediated by a
calcium diffusive gradient. It appears that another mechanism, perhaps release of intracellular
calcium stores prompted by the intercellular transport of secondary messengers such as IP 3, may
be the primary cause (refer to Discussion). The transient increases in intracellular calcium levels
achieved a maximum distance between 15-45 seconds after wounding, and consequently
mechanically wounding was performed directly on the microscope stage and cells were
immediately visualized (Figure 9). Calcium distances were measured as the maximum distance
of calcium traveled in a field of view.
Control cultures tended to show elevated levels of calcium approximately 11.0±2.83 cells
from the wound edge (Table 7). Within five minutes of wounding, calcium levels appeared to be
markedly reduced and returned to unwounded levels, likely because of a combination of the
transitory behavior of calcium excitation and to a lesser extent because of photobleaching. It
should be noted that despite other experimenters' observation of regenerative calcium waves in
other cell systems including astrocytes, cardiac myocytes, and even vascular smooth muscle
cells, such behavior was not observed in the porcine aortic endothelial cells, demonstrating the
differences between excitable and non-excitable cells.
Sequences whose levels of connexin 43 had been reduced by RNA interference exhibited
drastically different response to mechanical injury compared to control sequences. Upon
mechanical wounding, the first row adjacent to the wound edge immediately was illuminated
similar to the control sequences. However, the average number of cells rows that showed
elevated levels of calcium was markedly reduced (P < 0.05), at only 2.8±1.03 rows (Figure 9 and
Table 7). This resulted in an approximately 74.6% reduction in intercellular communication as
measured by intracellular calcium levels. Interestingly, the connexin 43 reduced sequences
exhibited a similar transient decrease in calcium intensity at the wound edge, with levels falling
off after several minutes. The larger standard deviation of distance relative to the mean in
connexin 43 silenced cultures can be explained by variations from culture to culture in the
efficiency of the transport vehicle in delivering the RNA.
Table 7. Quantitative comparison of calcium excitation distance from the wound edge in
porcine aortic endothelial cells. P<0.05, Student's T-Test.
Mean number Standard n
of cell rows Deviation
traveled
Control 11.0 2.83 5
Inhibited 2.8 1.03 10
Connexin 43
Control
Figure 10. Intercellular calcium transfer is reduced after down-regulation of connexin 43.
Calcium transfer was determined via Fluo-4 tracer analysis and images were captured at the
maximum transfer distance of the transient calcium response.
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3.4 Reduction of connexin 43 through RNA interference reduces diffusive transfer of low
molecular weights markers (<1 kDa) through gap junctions
PAEC cells were mechanically wounded and were tested for intercellular transfer of
fluorescent dyes to measure diffusive transfer through gap junctions. Because the scrape loading
of the dyes loaded only the cells adjacent to the wound edge, cells were incubated for 15 minutes
to allow for adequate diffusive transfer through gap junctions before fixing with
paraformaldehyde. Images and measurements were not taken of live cells but of chemically
fixed cells, and consequently the this thesis did not focus on the temporal characteristics of
intercellular diffusion through gap junctions. Furthermore, because cells were washed twice and
the dye transfer assays were performed in PBS rather than in growth medium, the short-term
effect of the media on growth factor activation of the cells via growth factor activation are likely
at a minimum. Because of the strong fluorescent nature of Lucifer yellow, our results indicated
that 0.5 mg/ml to be the optimal concentration in which to conduct the scrape-loading of the
cells.
After scrape loading of control cultures of PAEC cells, there appeared to be a clear
concentration gradient of Lucifer yellow (Figure 10), with the Lucifer yellow dye traveling
5.3±0.6 cells from the wound edge. Because Lucifer dye transfer is governed by diffusion rather
than calcium excitation, intensity was much brighter at the wound edge than towards the
monolayer. In comparison, the diffusion distance of the Lucifer yellow dye in cultures with
reduced connexin 43 through RNA interference was itself decreased 57%, to 2.3±0.5 cells (P <
0.05) from the wound edge. Like the control cultures, samples that had connexin 43 reduced
exhibited a gradient of Lucifer yellow intensity moving out from the wound edge. Similar
diffusive transfer can be seen in the intercellular transfer of neurobiotin, thought to exhibit
selective permeability characteristics (see Figure 11). Overall transfer appeared to be longer than
Lucifer yellow dye, and connexin 43 silencing did not appear to minimize diffusive transfer as
much as it did in the transfer of Lucifer yellow.
Table 8. Quantitative analysis of Lucifer yellow dye transfer
via siRNA. P<0.05, Student's T-Test.
after connexin 43 inhibition
Mean number Standard n
of cell rows Deviation
traveled
Control 5.3 0.6 3
Inhibited 2.3 0.5 4
Connexin 43
Control
Connexin 43 inhibited
Figure 11. Inhibition of transfer of Lucifer yellow dye through gap junctions via siRNA
inhibition of connexin 43 in porcine aortic endothelial cells.
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Figure 12. Intercellular transfer of neurobiotin through gap
junctions after mechanical injury in porcine aortic endothelial
cells.
3.5 Selective inhibition ofgapjunctions alters the wound closure rate in PAECs.
Porcine aortic endothelial cells were mechanically wounded and treated with connexin
mimetic peptides to explore the role of gap junctions in wound closure. Because the mimetic
peptides take up to 30 minutes to inhibit gap junction communication [33], cells were
preincubated with the connexin mimetic peptides dissolved in growth medium. After the
preincubation, cells were wounded as described (Chapter 2). After 24 hours in culture, samples
were aspirated and appropriate fresh media was added to the samples. Results indicate that
connexin 37 appears to play a different regulatory role than connexin 43 in the mechanically-
induced wound repair process, and that endothelial cells with both regulatory connexins inhibited
exhibit an altogether different behavior. These results were unfortunately not verified as
statistically significant by the Student's T-Test.
As predicted, wounds did not appear to lose their linear closure rate, as determined by
regression analysis (Table 9). Despite the maintenance of linear growth behavior, after 35
hours monolayers whose gap junction docking of both connexin 37 and connexin 43 had been
inhibited by addition of equal concentrations of 3740Gap26 and 43Gap43 mimetic peptides
exhibited the largest distance of wound closure (Figure 12). The cultures that closed mechanical
wounds the next closest were
Table 9. Porcine aortic endothelial cells maintain a linear rate of wound
closure after inhibition of gap junction formation by connexin mimetic
peptides. Linear behavior determined by regression analysis.
Condition R value
Control 0.9979
43Gap26 0.9983
3740Gap26 0.9969
43Gap26 + 3740Gap26 0.9958
0 500 1000 1500 2000 2500
Time (minutes)
- - Linear (26Gap43 + 26Gap3740) - - Linear (26Gap3740) - Linear (Control)- - - Linear (26Gap43)
Figure 13. Time-dependent wound closure of mechanically injured porcine aortic
endothelial cell monolayers in response to connexin mimetic peptides. Culture media was
replaced by fresh media with dissolved connexin mimetic peptides at 0 and 24 hours after
wounding.
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those treated with 26Gap3740 inhibitory peptide and control sequences, which exhibited
essentially the same growth rate. Surprisingly, cultures that regulated only connexin 43
exhibited the slowest closure rate over the 35 hours period.
Because wound distances were measured every few hours, the initial distances of closure
were also analyzed in all samples (Figure 13). The results suggest that for the first four and a
half hours after wound closure, inhibition of the docking of connexin 43 into gap junctions
speeds the wound closure rate, whether or not this is done in conjunction with inhibition of
connexin 37. The limited number of connexin mimetic peptides that could be used in
experiments restricted the sample number (n=4). Nevertheless, during the first 4.5 hours cultures
treated with a connexin 43 inhibitor exhibited a wound closure rate 167% (connexin 43 inhibitor
alone) and 164'/o (in conjunction with 3740Gap26) of controls. This difference was even
pronounced during the first two hours of this initial period, when the 43Gap26 and
43Gap26+3740Gap26 samples exhibited closures that were 236% and 178% of controls. Thus,
for the first two hours it appears that connexin 43 inhibition alone speeds wound closure more
than when connexin 37 is simultaneously prevented from forming gap junctions. After two
hours, it appears that the effect of connexin 43 and connexin 37 inhibition is additive and neither
connexin inhibited alone speeds up wound closure as much as the two used together in equal
concentrations.
From 7 to 18 hours, cultures where all gap junction formation had been inhibited
exhibited the highest rate of wound closure, followed by those that had connexin 37 inhibited
alone. In fact, connexin 43 inhibition alone resulted in no difference from control cultures in
wound repair, or at best a slight decrease.
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Figure 14. Differential wound healing during the initial 4.5 hours after mechanical injury
in porcine aortic endothelial cells treated with connexin mimetic peptide gap junction
inhibitors.
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Figure 15. Differential wound healing of connexin inhibitor-treated samples during hours 7
to 18 after mechanical injury.
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3.6 Selective connexin regulation alters macroscopic vascular function
Human umbilical vein endothelial cells and porcine aortic endothelial cells were
examined to see the effects of specific regulation of gap junction functionality on the production
of eicosanoids and proteins that are known to regulate vascular function in post-confluent or
mechanically wounded monolayers. Connexin mimetic peptides have been used successfully in
culture before, but cells were still examined for death and the peptides did not appear to have any
toxic effects on histological phenotype - cell size, shape, and confluency between all conditions
looked the same (data not shown). Furthermore, a BCA total protein assay was conducted on 24
hour conditioned media of HUVEC cells for both normal and wounded post-confluent
monolayers. Results show that total protein between unwounded samples remained largely
unchanged when gap junctions were inhibited (Figure 15). Similarly, total protein between
wounded monolayers did not appear to be drastically different for control and gap junction
inhibited samples. However, results do show that wounded cultures did produce less total
protein than their unwounded counterparts (P < 0.05). This was consistent between all
experimental conditions. Protein concentration was determined by establishing a standard curve
of bovine serum albumin, and concentration was linearly proportional to absorbance
(R2=0.9904).
Control 43GAP26 3740GAP26 43GAP26 and 3740GAP26
I Non-Wounded Samples 0 Wounded Samples
Absoaecs (A.U.)
Figure 16. Total protein concentration after 24 hours in control and connexin mimetic
peptide-treated human umbilical vein endothelial cells (HUVEC). Total protein
concentration in wounded and non-wounded samples remained unchanged after addition of
connexin mimetic peptides. Wounded sample proteins concentrations were determined to be
statistically different than unwounded samples (P < 0.05). Standard Curve used to determine
total protein concentration shown in bottom graph.
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3.61 Changes in endothelial cell production of TGF-/3 after connexin mimetic peptide
treatment in unwounded and wounded cultures
Once the use of connexin mimetic peptides was established, PAEC cultures were
examined for changes in TGF-3 in response to gap junction regulation. Because porcine
genome-specific detection kits were not commercially available for endothelial nitric oxide
synthase or 6-keto-prostaglandin Fl,, TGF-3 was the only vascular regulator examined. Results
indicate that regulation of gap junctions significantly reduces the concentration of latent TGF-3
(P < 0.05, Figure 16). This decrease occurred in all experimental conditions, regardless of the
type of
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Figure 17. Total TGF-P concentration in connexin mimetic treated porcine aortic
endothelial cells (PAEC). Conditioned media was collected 24 hours after in-vitro
administration of connexin mimetic peptides to media. Latent TGF-3 was chemically activated,
and total concentration was determined. P < 0.05, Student's T-Test.
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connexin protein regulated. The level of total TGF-3 in the 43Gap26, 3740Gap26, and
43Gap26+3740Gap26 cultures was 191.1+16.7, 181.2±5.8, and 197.8±58.9 pg/ml compared to
263.4+41.2 pg/ml in the control cultures. There was no significant difference seen in the level of
active TGF- P in any of the samples, or compared to unconditioned media (data not shown).
Concentrations of TGF-3 in conditioned media were examined in response to gap
junction regulation via connexin mimetic peptides in HUVEC cells. TGF- P in HUVECs did not
respond in the same manner as in PAECs. Yet, the total levels of the protein in HUVECs
appeared to be around four times higher than in porcine cells (Figure 17). Specifically, TGF-3
levels in PAEC cells ranged from 181.2 pg/ml to 263.4 pg/ml, depending on the condition, while
they were in the range of 749.5 pg/ml to 860.8 pg/ml in HUVEC cells. 24 hours after addition of
connexin mimetic peptides, non-wounded samples did not appear to show a significant
difference between control and samples with inhibited gap junction communication. There
appeared to be a very slight but insignificant increase in the amount of TGF-3 production in
samples that had connexin 37 and connexin 40 inhibited, to 822.3±173.3 pg/ml compared to
749.5±46.4 pg/ml for controls (Figure 17). Connexin 43 appeared to play a slightly more
stimulatory role in upregulating TGF- P production in post-confluent samples, raising levels to
822.3±173.3 pg/ml and 857.1±223.2 pg/ml in the 43Gap26 and 43Gap26+3740Gap26
conditions, respectively.
Upon wounding of cultures, the stimulatory roles of connexins with respect to TGF- P did
not appear to be the same as in post-confluent HUVEC monolayers. The results suggest that in
wounded monolayers, the inhibition of all connexin proteins significantly reduces the amount of
TGF-3 in the conditioned media (P < 0.05), while for the first 24 hours after wounding inhibiting
either connexin 37 or connexin 43 alone does not seem to effect TGF-1 levels (Figure 18).
While control, 43Gap26, and 3740Gap26 statistically had the same TGF-P levels (673.1±65.9
pg/ml, 692.0±59.2 pg/ml, and 600.5±95.6 pg/ml respectively), as soon as both 43Gap26 and
3740Gap26 was added to conditioned media, there was a decrease in production to 590.7±77.3
pg/ml.
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Figure 18. TGF-p concentration in HUVECs 24 hours after incubation with connexin
mimetic peptides. Conditioned media was collected from non-wounded cultures and examined
via ELISA for human TGF-P.
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Figure 19. TGF-p concentration in mechanically wounded HUVECs 24 hours after
treatment with connexin mimetic peptides. 43Gap26+3740Gap26 condition considered to be
statistically different from control (P < 0.05).
3.62 Regulation ofendothelial cell prostacyclin secretion by connexin mimetic peptide
inhibitors
Connexin mimetic peptides were used to examine the role of gap junctions on the
regulation of prostacyclin in post-confluent monolayers and mechanically wounded HUVEC
cells. Because of the short 3 minute half life of prostacyclin, and its subsequent hydrolysis to 6-
keto-prostaglandin Fl,, the concentration of the latter eicosanoid was determined by enzyme
immunoassay. In unwounded post-confluent monolayers, inhibition of connexin 43 alone barely
reduced the levels of 6-keto-prostaglandin Fl (Figure 19). However, the levels were further
reduced when connexins 37, 40, and 43 were inhibited by the connexin mimetic peptides. The
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inhibition of only connexins 37 and 40 yielded similar 6-keto-prostaglandin Fla concentrations as
control experiments. Thus, it appears the complete elimination of gap junction communication
shows a trend of reducing the levels of 6-keto-prostaglandin Fla in HUVECs.
Inhibition of connexins appeared to have a noticeable increase in the levels of
prostacyclin secreted. Upon mechanical wounding of post-confluent HUVEC cells, inhibition of
connexin 43 alone significantly increased the levels of 6-keto-prostaglandin Fla in 24 hour
conditioned media (P < 0.05, Figure 20). All samples showed strikingly similar increases in the
levels of prostacyclin, with 43Gap26, 3740Gap26, and 43Gap26+3740Gap26 having
concentrations of 7.75±0.88 pg/ml, 7.77±0.24 pg/ml, and 7.54±0.57 pg/ml, respectively,
compared to the control sample concentration of 6.43±0.37 pg/ml.
These values were calculated by treating the region of the standard curve to which the
absorbance values at 450 nm corresponded as linear (R2=0.9987). The percent bound, % B/Bo0,
was calculated for the standard curve and was found to be similar to the standard curve provided
in manufacturer's instructions (data not shown).
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Figure 20. Formation of 6-keto-prostaglandin Fl. after treatment with connexin mimetic
peptides in HUVECs. Because of the small half life of prostacyclin (3 minutes) and
spontaneous hydrolysis to 6-keto-prostaglandin Fl,, the latter is accepted as a measure of
prostacyclin formation.
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Formation of 6-keto-prostaglandin Fl. in mechanically wounded HUVECs after
with connexin mimetic peptides. Treatment with 3740Gap26 statistically
(P < 0.05).
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3.63 Changes in levels of the membrane-bound protein endothelial nitric oxide synthase
(eNOS) after inhibition of gap junction communication
Levels of the exclusively membrane-bound protein endothelial nitric oxide synthase
(eNOS) were determined by cell lysis and subsequent ELISA immunoassay. When all gap
junction communication was inhibited by the addition of both 43Gap26 and 3740Gap26 mimetic
peptides to post-confluent monolayers, the concentration of membrane-bound eNOS
significantly increased 40% from 12,704 pg/ml in control cultures to 17,630 pg/ml (P < 0.05,
Figure 21). The levels of membrane-bound eNOS in cultures with only connexin 43 or connexin
37 and connexin 40 inhibited showed very little difference from control cultures, at 11,732 pg/ml
and 13,476 pg/mrl, respectively.
Upon wounding of HUVEC monolayers that had both connexin 43 and connexin 37/40
inhibited, there was an approximately 30% decrease in the concentration of membrane-bound
eNOS rather than the 40% increase seen in non-wounded samples. 24 hours after addition of the
connexin mimetic peptides, eNOS concentration was 11472 pg/ml compared to 16144 pg/ml in
control samples (Figure 22). Regulation of only connexins 37 and 40 did not appreciably change
the levels of eNOS (16198 pg/ml compared to 16144 pg/ml for controls). Lastly, inhibition of
only connexin 43 slightly decreased the levels of eNOS compared to controls to 14716 pg/ml. It
should be noted that this decrease eNOS was not as large as that seen when connexins 37, 40,
and 43 were all inhibited (Figure 22). Wounded samples were not considered statistically
different from controls.
43Gap26 + 3740Gap26
Figure 22. Endothelial Nitric Oxide Synthase (eNOS) concentration in post-confluent
HUVECs 24 hours after treatment with connexin mimetic peptides to regulate gap junction
function. 43Gap26 + 3740Gap26 sample statistically different from control, P < 0.05.
43Gap26 + 3740Gap26
Figure 23. Endothelial Nitric Oxide Synthase (eNOS) concentration in mechanically
wounded HUVECs 24 hours after treatment with connexin mimetic peptides to regulate
gap junction function.
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4. DISCUSSION
Gap junctions are mediators of intracellular coupling, and have recently been implicated
along with autocrine/paracrine binding as the driving force of cellular communication over short
distances [59]. The distances over which gap junction-mediated signals propagate varies with
cell and system. For example, gap junctions regulate astrocytes communication over lengths
great than 20 cells, and excitable cells such as cardiac myocytes rely on gap junction
communication at the resting potential, but the role of endothelial cell gap junctions in
maintaining vascular homeostasis is still unclear. To date, the vast majority of studies on
endothelial gap junctions have focused on the role of mechanical wounding, growth factors (i.e.
VEGF, FGF, TGF-03, and PDGF) and pathological states (i.e. hypertension, bradycardia) on
connexin levels. Studies of the role of connexins in vascular function appear to provide
conflicting data. In part this arises from species and vascular location-specific effects of gap
junctions on the endothelium [4]. Recently, demonstration of the non-specificity of
immunocytochemical techniques have been implicated for the inconsistencies between even
similar cell types [6]. Most importantly, until recently methods did not exist to specifically
regulate gap junction communication at the functional or transcriptional level. To circumvent
many of the hurdles encountered by other researchers, we avoided problematic cell types, such as
mouse endothelial cells, as well as assays whose specificity were not unequivocal. Porcine aortic
endothelial cells were chosen to examine the role of connexin 43 in diffusive transfer of low
molecular weight dyes and also in calcium excitation of neighboring cells. PAECs require
minimal growth factors and supplements offering a critical advantage over human endothelial
cells, which require high levels of both.
This study is the first to report the specific transcriptional silencing of any gap junction
protein in porcine endothelium. In addition, gap junctions were for the first time shown to
mediate changes in the levels of TGF-P3, prostacyclin, and endothelial nitric oxide synthase
(eNOS). These results together suggest that connexins in the endothelial do not merely for
channels which provide for the passage of unimportant small molecules, but that connexins each
play a different role in maintaining vascular function.
4.1 Specific downregulation of connexin 43 decreases the permeability of gap junctions
4.11 Diffusive transfer offluorescent dyes through endothelial gap junctions is dependent on
the number of gapjunctions containing connexin 43
The first major result in this thesis is the successful silencing of gap junction
communication in primary aortic endothelial cells using RNA interference technology. The
results confirm that this platform can be used for the transient down-regulation of connexin 43
and complete lknockdown of the protein at 24 hours. Achieving up to a 97.4% reduction in
connexin 43 mRNA levels permitted the in-vitro exploration of diffusion of fluorescent dyes
through endothelial gap junctions, without the need for transgenic molecular modification.
Recently, work was performed on gap junctions of normal rat kidney epithelial cells to determine
the dye selectivity of homotypic gap junctions, normalized to channel conductance [60]. The
near elimination of connexin 43 mRNA via RNAi in culture should not affect dye selectivity,
since the selectivities were determined per individual gap junction. Instead, the reduction in the
diffusive transfer of Lucifer yellow dye through gap junctions indicates that reductions in
connexin 43 transcription reduces the number of homotypic connexin 43 gap junctions, and must
also effect both the heterotypic and heteromeric gap junctions that would contain that connexin
type. By reducing drastically the distance traveled by Lucifer yellow dye from 5.3±0.6 to
2.3±0.5, the results indicate that open gap junction channels containing connexin 43 play a
dominant role in the selective permeability of molecules in porcine aortic endothelial cells.
Although an in-depth analysis of neurobiotin transfer through gap junctions was not performed
as it was for Lucifer yellow, the results suggest that reduction in the levels of connexin 43 have a
different effect on the transfer of neurobiotin.
In 2001, Kriiger et al [8] demonstrated that Lucifer yellow transfer via iontophoretical
injection was reduced in connexin 40-deficient mice compared to controls, while the transfer of
neurobiotin was not. Our results, exploring the role of a different connexin in a species with
known gap junction compositional differences from mice suggest a different story. Neurobiotin
appears to travel more extensively than Lucifer yellow even in control sequences, and while the
distance is reduced in connexin 43 silenced samples, at first glance (Figure 11) they do appear to
still be farther than the transfer of Lucifer yellow. Thus, it is likely that downregulation of
connexin 43 in PAEC cells affected the transfer properties of neurobiotin by at least partially
reducing the assembly of heterotypic or heteromeric gap junctions comprised of both connexin
43 and other gap junction types. Because porcine aortic endothelium possess connexin 43 and
37 and not connexin 40, this leads us to conclude that connexin 43 silencing in PAEC cells
results in the reduction of connexin 37-connexin 43 heterotypic or heteromeric gap junctions.
However, we are not able to rule out that connexin 43 silencing leads to alterations in the mRNA
of connexin 37, as this was not examined.
4.12 Calcium excitation via permeation of lP 3 is significantly reduced in endothelial cells with
silenced connexin 43
While the role of gap junctions in the just described permeability studies is important to
understanding connexin-mediated gating mechanisms in the endothelium, the more interesting
question is the functional effects such connexin regulation may have. Calcium wave generation
is considered a hallmark function of gap junctions. However, because of the limited conductance
of endothelial cells, the study of calcium waves has primarily focused on vascular smooth
muscle and other cells [61]. Here, we demonstrated that calcium excitation can be considered a
phenomenon related to but different from diffusive transfer through gap junctions. In
microinjection and scrape loading of fluorescent dyes, the number of cells exhibiting coupling is
related to the permeability of the gap junctions and other factors including size and charge of the
fluorescent tracer. However, the distance traveled is certainly also dependent on the initial
concentration Co entering the first cell on the wound edge. Because of the high relative
concentration of Lucifer yellow and neurobiotin in the first row of cells at the wound edge, and
the near equal concentrations between those cells, it can be assumed that concentration gradients
of Lucifer yellow and neurobiotin do not exist parallel to the direction of the wound, but
perpendicular to it. Thus, on a first approximation, flow through endothelial gap junctions can
be assumed to be one-dimensional (Figure 23) and follow the initial conditions:
Cave(0,0)=0 Caye(oo,t)=O Cdye(O,t>O)=Co.
These conditions can be used to solve Fick's Law, 8C/at=Ddye(&2C/ax2 ).
The results of the calcium transfer studies indicate that increases in cytoplasmic calcium do not
follow one-dimensional diffusion according to Fick's Law. After reducing the levels of
connexin 43, the distance of calcium excitation dropped almost four fold from 11.0+2.83 to
2.83+1.03 cell rows. Yet, those cells that exhibited excitation of calcium all appeared to have
roughly the same intensity, whereas an intensity "gradient" was more apparent in the transfer of
Lucifer yellow and neurobiotin. This was apparent for both the control and connexin 43 silenced
sequences.
t=o
1. 1-D dye transter
2. Diffusion(EC-EC)>>Dlffusion(EC-vSMC)
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Figure 24. Transfer of low molecular weight (<1 kDa) through endothelial gap junctions.
To our knowledge, this is the first use of specific inhibitors (i.e. siRNA, connexin mimetic
peptides, transgenic animals, etc.) to implicate connexin 43 as a mediator of calcium wave
excitation in endothelial cells upon mechanical wounding. Thus, as the cell at the wound edge is
tx
excited by mechanical wounding, IP3 will travel through gap junctions, which according to these
results will primarily be homotypic containing only connexin 43 or heterotypic/heteromeric,
containing connexin 43 and a combination of other connexin types. Had the primary mediator of
IP3 transport been connexin 37, we would not have seen such a large decrease in intercellular
communication as we did.
As IP3 passes through gap junctions, it mobilizes calcium and prompts its temporary
release from the endoplasmic reticulum of neighboring cells. Thus, these results open a new
window for exploring the alteration of calcium wave excitation through a programmed mode of
connexin inhibition. It would be interesting to know what the effect of overexpressing connexins
in endothelial cells would be on calcium wave generation, both temporally and spatially. To
date, no publications appear to exist on the overexpression of connexins in endothelium. Our
laboratory has recently done work showing that the distance of calcium excitation can be
considerably extended in endothelial cells (-30 cells) via overexpression of phospholipase C
delta (PLC-6). A very compelling experiment would be to see whether this increase in distance
is dependent on the number of gap junctions, such as by reducing the mRNA of either connexin
43 or connexin 37.
4.13 Model of diffusional transport and calcium excitation in porcine aortic endothelial cells
Our combined results of dye transfer and calcium excitation allow us to formulate a
simple model that describes the role of gap junctions in intercellular coupling. Connexin 43 is
the primary gap junction protein in PAECs, and upon downregulation the distribution and
number of gap junctions changes (Table 10). As the total amount of connexin 43 is greater than
that of connexin 37, any increase in the number of connexin 37 homotypic gap junctions is in-
Table 10. Change in the distribution of gap junctions after
silencing of connexin 43.
Gap junction Type Connexin 43 RNAi
Connexin 43 homotypic 1
Connexin 37 homotypic "
Connexin 43/Connexin 37 heterotypic 1
Connexin 43/Connexin 37 heteromeric 1
sufficient to compensate for the decrease in connexin 43. As a result, the intercellular transport
of IP3 and fluorescent dye such as Lucifer yellow is significantly impeded.
4.2 Connexins 37, 40, and 43 differentially regulate the wound healing process in the
aortic endothelium.
The mechanical wounding studies in conjunction with connexin mimetic peptides show
that connexins play a role in mediating wound closure. These studies have particular relevance
in arterial injury of all forms, endogenous and imposed, where endothelial wound closure is a
critical process in preventing further complications and in directing complete repair. Two
studies altered connexin expression and explored the associated changes in wound closure rate
[34, 35]. The first, done in Pym-T transformed mouse brain endothelial cells that exhibit
characteristics of tumor cells, suggested that dominant negative knockdown of connexin 43
slows the healing process by 50%. The second paper used connexin 43 antisense gel on skin
excisional and incisional wounds and suggested that down-regulation of connexin 43 enhances
healing. An obvious advantage of our use of endothelial cells as opposed to epithelial cells or
transformed cells of brain endothelial origin is there relevance to vascular repair.
Our results allow us to propose a model of gap junction-mediated wound healing where
stimulatory signals are transmitted primarily through connexin 43-containing gap junctions and
inhibitory signals are transported through gap junctions containing connexin 37 (Table 11).
When all gap junction communication is inhibited, the wound closes at an unregulated rate and
might mimic that of a subconfluent monolayer, where gap junctions have not yet properly
formed. Unlike regulating connexins at the mRNA level, preventing the docking of a connexin
37 homotypic gap junction will not alter the number of connexin 43 homotypic gap junctions,
although it will increase its relative proportion to that of functional gap junctions.
Table 11. Effect of gap junction composition on wound healing.
Inhibitory Mimetic Peptide
Gap junction Type 43Gap26 3740Gap26 43Gap26 +
3740Gap26
Connexin 43 homotypic 4 No change
Connexin 37 homotypic No change
Connexin 43/Connexin 37 heterotypic1 4
Connexin 43/Connexin 37 heteromeric 4
Net effect on wound closure I T IT
Inhibition of all gap junctions increased the wound closure rate the most compared to controls,
followed by only inhibiting connexin 37. The finding that connexin 43 inhibition by itself slows
wound healing is in accord with findings by Kwak et al [35] in transformed brain endothelial
cells, yet our results indicate that connexin 37 also plays an important role in the healing of
porcine endothelium. This thesis presents the first report of differential roles of connexin 37 and
connexin 43 in the wound healing process, and indicates that regulation of multiple gap junction
proteins in concert with growth factor treatment may be a rational method of increasing the
wound closure rate after arterial intervention or injury.
Furthermore, looking at specific time period reveals more information about the specific
connexin roles. During the first two hours after wounding, cells are exclusively spreading and
migrating, and not proliferating, and connexin 43 appears to triple the rate of wound closure.
Thus, for very small wounds that close exclusively through migration in the endothelium,
connexin 43 inhibition using mimetic peptides may offer a strategic therapeutic tool. During
these early hours of wound repair, inhibition of connexin 37 does not seem to effect wound
repair, though it would be hasty to predict what effect overexpression of connexin 37 might have
during these early hours. It is interesting to note that in Pepper et al's [16] 1992 paper on wound
healing in bovine microvascular endothelium, connexin 43 mRNA in wounded cultures
increased immediately after wounding and peaked after four hours, returning to control levels
after 24 hours. Although his study did not explore the mRNA levels of other connexin types,
and the endothelial cell type was altogether different, our findings implicating connexin 43 as the
"master" connexin during the early hours of wound healing certainly agree with his results.
During hours 0-2 there is a 3-fold increase in healing rate of connexin 43 inhibited cells.
The repair process is not stimulated only when connexin 37 is inhibited alone, but is when it is in
conjunction with connexin 43 inhibition. Normally, endothelial proliferation begins
approximately 24 hours after wounding. During hours 30-35 cultures with the addition of
3740Gap26 inhibitory peptide heal 81% faster than control cultures (data not shown). In
addition, addition of all gap junction inhibitors increased the healing rate by 34%, while
exclusively adding 43Gap26 reduced healing 13%. Unfortunately, these results were not verified
as statistically significant and must be repeated with larger sample size.
The data indicate that that the role of gap junctions in the wound healing process is far
more complex than that has been suggested in the past. Unfortunately, the data are limited by
the sparse availability of connexin mimetic peptides and lack of long duration access to time-
lapse microscopy. Yet, the results suggest that connexin 43 and connexin 37 exhibit stimulatory
and inhibitory roles in the wound healing process, respectively, and provide an impetus for the
experiments to be repeated with greater sample size, in vivo, and perhaps even with growth
factor treatment.
4.3 Connexins are significant regulators of TGF-PJ, prostacyclin, and eNOS in both the
unwounded and wounded state.
The lack of changes in total protein in post-confluent HUVEC cells after treatment with
connexin mimetic peptides is not surprising, and neither is the lack of change in wounded
cultures. Yet, TGF-P, prostacyclin, and eNOS are differentially regulated in control and
wounded cultures and with connexin mimetic peptides. The results are significant in showing
the importance of cell type in the function of gap junctions, as well as the vital role of gap
junctions in maintaining vascular homeostasis. A summary of the findings are shown in Table
12.
Table 12. Effect of changes in gap junction composition on the protein levels of
the vascular regulators TGF-P, prostacyclin, and eNOS in the unwounded and
wounded state.
Condition Re2ulator Connexin Inhibitor(s)43Gap26 3740Gap26 43Gap26 + 3740Gap26
PAEC (unwounded) TGF-P 4
TGF-P = = =
HUVEC (unwounded) Prostacyclin = =
eNOS = = T
TGF-P = , =
HUVEC(wounded) Prostacyclin t T I
eNOS = =
TGF-P Neither control or connexin-inhibited cultures of PAEC or HUVECs
secrete active forms of TGF-P. Indeed active TGF-3 is secreted by few primary cultures, namely
BSC-1 African green monkey kidney cells [62]. Endothelial cells and many other types of cells
secrete TGF-3 in a latent form, and the latent binding protein is cleaved extracellularly.
Nevertheless, the present study appears to be the first to report that connexin 37 and connexin 43
both down-regulate release of latent TGF-3 into conditioned media in any endothelial cell type,
regardless of species. All connexin mimetic peptide samples, whether 43Gap26, 3740Gap26, or
3740Gap26+43Gap26, serve to effectively reduce TGF-P secretion by at least 30% in PAEC
cells (Fig. 16). Yet, since the porcine TGF-1 ELISA kit is not part of the newer generation of
TGF-3 kits from R&D Systems with greater well-to-well consistency, further experimentation
and/or alternative method of measuring porcine TGF-3 would be in order. In contrast to our
PAEC findings connexin inhibition did not result in a marked change in HUVEC secreted TGF-3
in unwounded samples. Mechanical wounding and complete inhibition of connexin proteins did
significantly decrease latent TGF-3 levels, with a smaller reduction with only connexin 37
inhibited, but no change in the wounded, connexin 43 inhibited cells compared to controls.
A variety of possible explanations might help understand the discrepancy between the
role of specific gap junctions and TGF-3 secretion in PAEC versus HUVEC cells. While PAEC
cells were grown in DMEM with 5% FBS, HUVEC cells were grown in EBM-2 with 7% FBS,
in addition to supplements including heparin binding-epidermal growth factor (HB-EGF),
hydrocortisone, VEGF, FGF2, insulin growth factor, and heparin. It is possible that any of
combination of these supplements affected the cells' response to reduction in different types of
gap junctions. Related to this issue is that the HUVEC cells produce more than four times as
much TGF-0 as the PAEC cells in the same gap junction regulation conditions. Perhaps
HUVEC cells constitutively express TGF-3 at a higher rate than PAEC cells, and are less
susceptible to elements that may regulate its production, in this case gap junction
communication. Most likely, however, is that HUVECs are from a different endothelial origin
than PAEC cells, and may respond differently than adult endothelial cells under certain
circumstances, as has been shown in previous studies [63].
In light of these slightly contradictory yet exciting results, we can nevertheless conclude
that connexin 4:3 and connexin 37 inhibition change levels of latent TGF-P, depending on cell
type and wounded state. This is a profound finding that has significant implications in the field
of vascular medicine and the biomedical engineering of therapies and treatments, and deserves
the attention of both clinicians and researchers in the field. While it may not be desirable to
reduce the secretion of TGF-3 in wounded cultures, it may be worthwhile to examine whether
connexin down-regulation may be a marker for propensity for post-angioplasty restenosis.
Prostacyclin and eNOS The last section of this thesis involved tracking changes in
the concentration of the vasoeffectors prostacyclin and eNOS in response to connexin regulation.
Prostacyclin acts on two axes of endothelial function, preventing platelet aggregation and serving
as a vasodilator. Prostacyclin secretion is significantly increased in atherosclerotic plaques [64],
and via activation by the thrombin pathway [65]. Our results strongly suggest that regulation of
connexin proteins signals endothelial cells to alter their production of prostacyclin in the
wounded state. The finding that simultaneous inhibition of connexin 43 and connexin 37
significantly decreases the production of prostacyclin may explain the correlation of
hypertension and bradycardia with removal of gap junction communication. The more
significant finding, however, is the noteworthy increase in levels of prostacyclin after wounding
in all combinations of connexin mimetic peptide treatment. This finding is also the first of its
kind, linking removal of gap junction communication in wounded endothelium with increases in
the release of the prostacyclin. Interestingly, the differential effects of the various connexins
seen during the closure of wounds is not apparent in the up-regulation of prostacyclin production
-- connexins 43 and 37 appear to play parallel if not overlapping roles. In context, the increases
in prostacyclin in gap junction inhibited wounded cultures correspond to the correlation of
increased prostacyclin secretion in wounded cultures with temporary down-regulation of
connexins. After a week, prostacyclin levels return to control levels [65]. Thus, it appears that
the gap junction communication and prostacyclin release are inversely proportional at the
functional, rather than genetic level, as connexin mimetic peptides do no prevent the translation
of connexin proteins, but their docking into gap junctions.
Endothelial nitric oxide synthase (eNOS) is similarly critical for maintaining vascular
function, by inhibiting smooth muscle cell migration and proliferation, promoting endothelial
cell migration and proliferation, and acting as a vasodilator. In 2001, Liao et al reported that
mice deficient in connexin 43 in their endothelium exhibited hypertension and bradycardia [7].
In addition, they reported a 50% increase in plasma levels of nitric oxide (as measured by the
increase in nitrates and nitrites) in both connexin 43 heterozygous (+/-) and knockout (-/-) mice.
The authors suggested that enzymatic activity of eNOS is the explanation behind changes in the
levels of nitric oxide. The present work convincingly shows that simultaneous inhibition of
connexins 37, 40, and 43 in HUVEC cells increases the levels of eNOS, an exclusively
membrane bound protein. Thus, functional regulation of gap junction communication results in
a translational increase in eNOS production. Interestingly, Liao et al [7] showed that increases
in nitric oxide occurred with knockout of only connexin 43, while the results in this thesis show
that inhibition of only connexin 43 is not sufficient. Instead, the combined inhibition of
connexins 37, 40, and 43 is necessary. Previous studies have suggested that coordination
between endothelial cells and vascular smooth muscle plays a role in nitric oxide production.
The findings in this paper do not prove or refute that claim, yet the increases in nitric oxide
production were achieved without endothelial cell co-culture with vascular smooth muscle cells.
Surprisingly, there appeared to be a decrease in the levels of nitric oxide in connexin 37, 40, and
43 inhibited cultures upon wounding, while the inhibition of connexins 37 and 40 together or the
inhibition of connexin 43 alone did not produce a difference from control cultures. As there does
not seem to be any published work linking gap junctions, monolayer wounding, and nitric oxide
production, it would be hasty to draw any conclusions before further experiments are conducted
on this topic.
5. CONCLUSIONS AND FUTURE WORK
It is apparent that endothelial gap junctions have the role of gatekeeper of diffusion of
low molecular weight molecules and more importantly, of regulators of vascular function. Even
today, after decades of research, gap junctions remain topics more of intellectual curiosity than
clinical relevance in the cardiovascular community, though they have recently become potential
therapeutic targets in the cancer community [45]. Through the successful use of specific
techniques with therapeutic potential, such as RNA interference and connexin mimetic peptides,
the present work has shown that regulation of gap junctions has far-reaching effects including
changes in intercellular coupling through diffusion, calcium wave generation, and wound
healing. Connexin 43 is implicated as a mediator of stimulatory signals during wound closure,
and connexin 37 is suggested to have an inhibitory effect. In addition, by showing the critical
role of gap junctions in the production of TGF-Pf, prostacyclin, and even eNOS, their importance
in macroscopic vascular function is now clearer than ever. It would be worthwhile for future
experimenters to explore whether an increase in the number of gap junctions, through the
overexpression of particular connexin proteins, would yield different results. Furthermore, as
growth factors such as VEGF have been implicated in the transient downregulation of gap
junctions, work should be done to create a model explaining whether the interaction between
growth factor signal transduction and gap junction communication plays a dominant role in
regulating vascular function.
Unfortunately, research on in-vivo RNA interference is in its infancy stage, and
researchers in academia and in industry are currently attempting to overcome its drug delivery
challenges. A major advantage of using either RNA interference or peptide inhibitors is their
reversibility, which is traditionally not possible in the case of transgenic mice. Yet before the
experiments should be considered in vivo, many of the methods done in this thesis merit
replication in connexin overexpression models. For example, such experiments might provide
the answer to whether increasing the sheer number of connexins increases the distance of
diffusion and/or the selectivity of gap junctions, and whether this extends to calcium excitation
and wound healing. Furthermore, researchers should use time-lapse microscopy in conjunction
with inhibition/overexpression of connexins to create a quantitative, predictive model of the
wound healing process and its relationship to gap junctions. The findings that the functional
inhibition of connexins alters the levels of TGF-P, prostacyclin, and eNOS deserves attention by
the medical research community, who should determine whether it may be beneficial to coat
drug-eluting stents with connexin regulators. In light of the present findings, at first glance it
appears that it may certainly be worthwhile. Furthermore, it may be useful to explore how
inhibition of gap junctions at certain times after wounding might differentially affect vascular
function compared to inhibition at the time of wounding. Lastly, from the consistence between
the transcriptional and functional targeting of connexins, it is likely that there is some vital
communication passing through the gap junctions, rather than association of the connexins with
other proteins, that are mediating the changes in diffusion, calcium excitation, wound healing,
and the levels of the vitally important TGF-P, prostacyclin, and eNOS. IP3 has already been
implicated as the molecule leading to calcium excitation, but to my knowledge the molecule
passing through gap junctions that is definitively responsible for the other changes has not been
identified at this time. Thus, while this thesis seems to have successfully answered questions in
the interesting world of endothelial gap junction communication, there is an endless number of
other interesting questions remaining to be answered before all the pieces of the jigsaw puzzle
are put together.
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